Jaguar Health out-licenses plant-based drug for schizophrenia
Drug Discovery World
MAY 31, 2024
Jaguar Health’s out-licensing agreement with Magdalena Biosciences to develop novel, natural prescription medicines derived from plants for mental health indications, has been expanded. ” The US schizophrenia market is projected to grow to $8.06 billion by 2030, according to a market research report by Market Research Future. .”
Let's personalize your content